Publication | Closed Access

Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease

Medicinal ChemistryAlzheimer's DiseaseBiochemistryMedicineMulti-targeted AgentsNatural SciencesRational Drug DesignPharmacological AgentDrug DevelopmentPharmacologyDrug Discovery